Rights issue in Aqualis ASA (formerly Clavis Pharma) (NO) — NOK 54 million

Carnegie acted as sole manager and adviser in the fully underwritten NOK 54 million rights issue to Aqualis ASA in connection with the acquisition of Aqualis Offshore. Aqualis ASA is a Norwegian public company focusing on building a profitable and successful business based on its key competences within the marine and offshore and healthcare sectors. November 2013.